UN Rejects Calls for Moratorium on Gene Drive Research

Activists claim the technology is too risky, but scientists advise the United Nations to continue to support gene drive research.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CDC, FRANK HADLEY COLLINS The United Nations (UN) biodiversity meeting, held in Mexico this month, could have ended poorly for scientists working on gene drives, genetic elements that can perpetuate specific mutations and may help cull dangerous mosquito populations. But in spite of environmental activists pushing the UN to ban gene drives, citing the risk of accidental release, the UN’s final agreement—penned December 16—merely urged caution in testing gene drives, Nature reported. Overall, the organization broadly supported further research in synthetic biology.

“I’m very relieved,” Andrea Crisanti, a molecular parasitologist at Imperial College London who works with gene drives, told Nature. “It would have been a disaster for developing the technology.”

By engineering mutations that render organisms infertile or less infectious, then perpetuating these mutations with gene drives, scientists may be able to reduce the occurrence of certain mosquito-born illnesses and cull invasive species. Gene drives have already been tested in yeast, fruit flies, and mosquitoes, and may soon be enlisted in the fight against malaria. One team hopes to conduct field trials in Africa as soon as 2024.

But critics have expressed concern that there is no international framework governing the use of gene drive technology, and some activists had hoped to use the UN meeting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies